.png)
incretin.diet
.png)
Which type are you?
Saxenda (generic: Plaobes)
Active ingredient
Liraglutide
Dosage interval
Once a day
Mechanism of action
GLP-1 receptor
maximum capacity
3.0mg
Weight loss effect
8.4% (52 weeks)
merit
Dosage can be adjusted according to physical condition
FDA Approval Date
2014年12月
Approved by the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Korea Ministry of Food and Drug Safety (MFDS)
Zepbound
Active ingredient
Tirzepatide
Dosage interval
Once a week
Mechanism of action
GLP-1/GIP receptor
maximum capacity
15.0 mg
Weight loss effect
22.7% (72 weeks)
merit
Fewer injections
FDA Approval Date
2023年11月
It has been approved for manufacturing and sales in Japan as an obesity treatment . The active ingredient is the same as that of the diabetes treatment drug "Manjaro."
.png)
Which drug is best for the patient? We will consider the patient's condition and wishes.
Based on your examination, your doctor will recommend the most appropriate treatment.
If you require a prescription medication, please consult your doctor.
What is Saxenda ?
The GLP1 injection Saxenda makes you feel less hungry and makes you feel full after eating a small amount of food.
It helps me to restrain my tendency to overeat and snack, and while I'm eating, a "second self" appears that tells me "you don't have to feel full."
GLP1 injection "Saxenda" places little strain on the mind and body, allowing you to lose weight and improve your constitution gently. In addition, our clinic offers the generic version "Praoves" so that we can deliver it to everyone at a lower price.
What is Zepbound ?
This drug stimulates not only GLP-1 (glucagon-like peptide) receptors but also GIP (glucose-dependent insulinotropic polypeptide) receptors. GLP-1 suppresses appetite, while GIP promotes insulin secretion to control blood sugar levels. These actions can lead to healthy weight management.
Zepbound may be a new option for weight management!
_edited.png)
_edited.png)
_edited.png)
Pricing Plans
PlaoBes
(generic version of Saxenda)
(1 bottle)
18mg
11,000
JPY
(tax included)
Minimum of 5 pieces can be prescribed (maximum 30 pieces) * Needle cost and shipping fee not included
First visit
If you would like to receive prescriptions at the member price, please register as a MyMedipro Prime member before your appointment .
The member price applies to those who make a reservation for Dr. Fujii's outpatient appointment every Monday .
For first-time patients as well as returning patients, we offer "nutritional consultations by registered dietitians, unlimited viewing and listening to content."
Special services are available.
Returning patients or those transferring
For drugs containing 7.5 mg or more of Zepbound,
We will provide further information in the future.
*If you wish to continue taking Zepbound 2.5mg,
You can continue your treatment at the same price as the first month.
If you would like to receive a prescription at the member price, please contact us before your appointment.
Please register for MyMedipro Prime membership.
Membership prices are available for those who make a reservation for Dr. Fujii's outpatient appointment every Monday.
Applies to:
.png)
Online medical appointment fee
Face-to-face appointment fee
Shipping fee (nationwide flat rate)
500
JPY
(tax included)
500
JPY
(tax included)
2000
JPY
(tax included)
Credit card payment accepted
Credit card payments are
We only accept Visa, MasterCard, JCB, American Express and Diners .
If you would like to pay by a method other than credit card, please consult with your doctor after your examination.
Bank transfer is also available. Please contact us for details.
This medical treatment is not covered by insurance. (The consultation fee is included in the price of the drug.)
Please note that in addition to the cost of medication (which is included in the medical fee), you will be responsible for reservation fees and shipping costs.
In case of cancellation, the booking fee will be refunded.
If you are unable to continue for medical reasons, please consult with your doctor.
We will refund the remaining service fees.
A clinic with a proven track record in treating diabetes and obesity
HDC Atlas Clinic
A diabetes clinic offering cutting-edge medical care
Cases requiring insulin therapy using new drugs
By reducing the number of patients, more patients will come to the hospital from all over the country.
Launching online medical consultations for obesity treatment
To date, we have treated over 1600 patients.
To spread correct knowledge about diabetes and obesity treatment
He has published many books
Director of HDC Atlas Clinic
Yoshihiko Suzuki
Doctor of Medicine MD, Ph.D.
Graduated from Keio University School of Medicine (Class of 62)
13 years (2005 to March 2018)
Former visiting professor at Nippon Medical School, member of the European Association for the Study of Diabetes, specialist at the Japan Diabetes Society
2016 Edition: Ranking of Best Doctors for the People
2018 Edition: Ranking of Best Doctors for the People
Ranking of Best Doctors for the Nation 2021~2023
He has published numerous papers.
20 articles in the Journal of the Japan Diabetes Society
15 articles in the American Diabetes Association Journal
5 articles in the European Journal of Diabetes
13 articles in the International Journal of Diabetes
Others include NEJM, Lancet , Metabolism, Neurology, February Letter, etc.
Part-time doctor at HDC Atlas Clinic
Shohei Fujii
Graduated from Yamaguchi University School of Medicine
Graduated from the doctoral course at Yamaguchi University Graduate School of Medicine
Member of the Japanese Society of Internal Medicine
Member of the Japanese Circulation Society
Member of the Japanese Society of Heart Rhythmology
Member of the Japanese Society of Cardiac Rehabilitation
Member of the Japanese Heart Failure Society
Cardiologist
Arrhythmia specialist
Internal medicine certified doctor
Cardiac rehabilitation instructor
Side effects and risks
Nausea, vomiting, loss of appetite, stomach upset, fatigue
Main Side Effects
Acute pancreatitis, intestinal obstruction, acute kidney injury
Serious Side Effects
Zepbound also carries the risk of rare, but more serious, side effects. For example, the risk of pancreatitis. If you experience severe upper abdominal pain or nausea, consult your doctor immediately.
Previous animal studies have shown an increased risk of medullary thyroid cancer and multiple endocrine neoplasia (MEN) type 2. Although this risk has not yet been fully elucidated in humans, Zepbound is contraindicated for use by people who have had these diseases in the past or have family members who have had these diseases. If you experience symptoms of a thyroid tumor (e.g., a mass in the neck, difficulty swallowing, difficulty breathing, persistent hoarseness), consult your doctor.
The use of Zepbound has also been associated with acute kidney injury, which may result from dehydration due to gastrointestinal side effects and may include nausea, vomiting, and diarrhea. Hemodialysis may also be required. Some of these events have been reported in patients with no known underlying renal disease. The majority of reported events occurred in patients who experienced nausea, vomiting, diarrhea, or dehydration.
Furthermore, it has been pointed out that rapid weight loss may affect internal organs and hormone balance. Therefore, regular health checks are essential when using Zepp Bound.
Atlas Building 1F, 5-3 Ichibancho, Chiyoda-ku, Tokyo
access
Tokyo Metro Hanzomon Line: 2 minutes walk from Hanzomon Station, Exit 5
Tokyo Metro Yurakucho Line: 7 minutes walk from Kojimachi Station, Exit 3